|
| 37321559 | Analytical and behavioral characterization of N-ethyl-N-isopropyllysergamide (EIPLA), an isomer of N[6] -ethylnorlysergic acid N,N-diethylamide (ETH-LAD). | Drug Test Anal | 2024 |
| 36083120 | In Vitro Metabolic Fate of the Synthetic Cannabinoid Receptor Agonists 2F-QMPSB and SGT-233 Including Isozyme Mapping and Carboxylesterases Activity Testing. | J Anal Toxicol | 2023 |
| 38056906 | Acute psychotropic, autonomic, and endocrine effects of 5,6-methylenedioxy-2-aminoindane (MDAI) compared with 3,4-methylenedioxymethamphetamine (MDMA) in human volunteers: A self-administration study. | Drug Test Anal | 2023 |
| 36477925 | Use of the head-twitch response to investigate the structure-activity relationships of 4-thio-substituted 2,5-dimethoxyphenylalkylamines. | Psychopharmacology (Berl) | 2023 |
| 36239626 | In vitro metabolic fate of the synthetic cannabinoid receptor agonists (quinolin-8-yl 4-methyl-3-(morpholine-4-sulfonyl)benzoate [QMMSB]) and (quinolin-8-yl 4-methyl-3-((propan-2-yl)sulfamoyl)benzoate [QMiPSB]) including isozyme mapping and carboxylesterases activity testing. | Drug Test Anal | 2023 |
| 36321499 | Analytical profile of the lysergamide 1cP-AL-LAD and detection of impurities. | Drug Test Anal | 2023 |
| 34022102 | Separating the wheat from the chaff: Observations on the analysis of lysergamides LSD, MIPLA, and LAMPA. | Drug Test Anal | 2022 |
| 35524430 | Analytical profile, in vitro metabolism and behavioral properties of the lysergamide 1P-AL-LAD. | Drug Test Anal | 2022 |
| 35142073 | Addressing the challenges in forensic drug chemistry II. | Drug Test Anal | 2022 |
| 34750565 | (2-Aminopropyl)benzo[β]thiophenes (APBTs) are novel monoamine transporter ligands that lack stimulant effects but display psychedelic-like activity in mice. | Neuropsychopharmacology | 2022 |
| 34837347 | Return of the lysergamides. Part VII: Analytical and behavioural characterization of 1-valeroyl-d-lysergic acid diethylamide (1V-LSD). | Drug Test Anal | 2022 |
| 32880103 | Synthetic cannabinoid receptor agonists: Analytical profiles and development of QMPSB, QMMSB, QMPCB, 2F-QMPSB, QMiPSB, and SGT-233. | Drug Test Anal | 2021 |
| 33487513 | Comparative effects of (S)-ketamine and racemic (R/S)-ketamine on psychopathology, state of consciousness and neurocognitive performance in healthy volunteers. | Eur Neuropsychopharmacol | 2021 |
| 34884800 | Interaction Profiles of Central Nervous System Active Drugs at Human Organic Cation Transporters 1-3 and Human Plasma Membrane Monoamine Transporter. | Int J Mol Sci | 2021 |
| 34436449 | In Vitro Metabolic Fate of the Synthetic Cannabinoid Receptor Agonists QMPSB and QMPCB (SGT-11) Including Isozyme Mapping and Esterase Activity. | Metabolites | 2021 |
| 32372465 | Syntheses and analytical characterizations of novel (2-aminopropyl)benzo[b]thiophene (APBT) based stimulants. | Drug Test Anal | 2020 |
| 33860183 | Investigation of the Structure-Activity Relationships of Psilocybin Analogues. | ACS Pharmacol Transl Sci | 2020 |
| 31756337 | Pharmacological and biotransformation studies of 1-acyl-substituted derivatives of d-lysergic acid diethylamide (LSD). | Neuropharmacology | 2020 |
| 31917152 | Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species. | Neuropharmacology | 2020 |
| 31943218 | Prodrugs of New Psychoactive Substances (NPS): A New Challenge. | J Forensic Sci | 2020 |
| 32803833 | Analytical profile of N-ethyl-N-cyclopropyl lysergamide (ECPLA), an isomer of lysergic acid 2,4-dimethylazetidide (LSZ). | Drug Test Anal | 2020 |
| 32875347 | The psychoactive aminoalkylbenzofuran derivatives, 5-APB and 6-APB, mimic the effects of 3,4-methylenedioxyamphetamine (MDA) on monoamine transmission in male rats. | Psychopharmacology (Berl) | 2020 |
| 32415750 | Pharmacokinetics and subjective effects of 1P-LSD in humans after oral and intravenous administration. | Drug Test Anal | 2020 |
| 32180350 | Return of the lysergamides. Part VI: Analytical and behavioural characterization of 1-cyclopropanoyl-d-lysergic acid diethylamide (1CP-LSD). | Drug Test Anal | 2020 |
| 30298278 | Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA). | Psychopharmacology (Berl) | 2019 |
| 30188017 | Interactions of phenethylamine-derived psychoactive substances of the 2C-series with human monoamine oxidases. | Drug Test Anal | 2019 |
| 31299701 | Phenethylamine-derived new psychoactive substances 2C-E-FLY, 2C-EF-FLY, and 2C-T-7-FLY: Investigations on their metabolic fate including isoenzyme activities and their toxicological detectability in urine screenings. | Drug Test Anal | 2019 |
| 31181490 | Validation of an LC-MS/MS method for the quantitative analysis of 1P-LSD and its tentative metabolite LSD in fortified urine and serum samples including stability tests for 1P-LSD under different storage conditions. | J Pharm Biomed Anal | 2019 |
| 31152702 | Pharmacological characterizations of the 'legal high' fluorolintane and isomers. | Eur J Pharmacol | 2019 |
| 31033229 | Syntheses and analytical characterizations of the research chemical 1-[1-(2-fluorophenyl)-2-phenylethyl]pyrrolidine (fluorolintane) and five of its isomers. | Drug Test Anal | 2019 |
| 31083768 | Return of the lysergamides. Part V: Analytical and behavioural characterization of 1-butanoyl-d-lysergic acid diethylamide (1B-LSD). | Drug Test Anal | 2019 |
| 30789291 | Comparison of the behavioral effects of mescaline analogs using the head twitch response in mice. | J Psychopharmacol | 2019 |
| 30904940 | 2-Aminoindan and its ring-substituted derivatives interact with plasma membrane monoamine transporters and α<sub>2</sub>-adrenergic receptors. | Psychopharmacology (Berl) | 2019 |
| 30617391 | In vitro metabolic fate of nine LSD-based new psychoactive substances and their analytical detectability in different urinary screening procedures. | Anal Bioanal Chem | 2019 |
| 30443792 | Correction to: Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA). | Psychopharmacology (Berl) | 2019 |
| 30385253 | Comparison of the behavioral responses induced by phenylalkylamine hallucinogens and their tetrahydrobenzodifuran ("FLY") and benzodifuran ("DragonFLY") analogs. | Neuropharmacology | 2019 |
| 28823611 | Pharmacological profile of methylphenidate-based designer drugs. | Neuropharmacology | 2018 |
| 30105474 | Phencyclidine-Based New Psychoactive Substances. | Handb Exp Pharmacol | 2018 |
| 29908239 | The psychostimulant (±)-cis-4,4'-dimethylaminorex (4,4'-DMAR) interacts with human plasmalemmal and vesicular monoamine transporters. | Neuropharmacology | 2018 |
| 30196446 | 1,2-Diarylethylamine- and Ketamine-Based New Psychoactive Substances. | Handb Exp Pharmacol | 2018 |
| 30269490 | DARK Classics in Chemical Neuroscience: Aminorex Analogues. | ACS Chem Neurosci | 2018 |
| 30478735 | Self-Experiments with Psychoactive Substances: A Historical Perspective. | Handb Exp Pharmacol | 2018 |
| 28371351 | Identification of pyrolysis products of the new psychoactive substance 2-amino-1-(4-bromo-2,5-dimethoxyphenyl)ethanone hydrochloride (bk-2C-B) and its iodo analogue bk-2C-I. | Drug Test Anal | 2018 |
| 28342193 | Metabolism of the tryptamine-derived new psychoactive substances 5-MeO-2-Me-DALT, 5-MeO-2-Me-ALCHT, and 5-MeO-2-Me-DIPT and their detectability in urine studied by GC-MS, LC-MS<sup>n</sup> , and LC-HR-MS/MS. | Drug Test Anal | 2018 |
| 29673128 | Synthesis, analytical characterization, and monoamine transporter activity of the new psychoactive substance 4-methylphenmetrazine (4-MPM), with differentiation from its ortho- and meta- positional isomers. | Drug Test Anal | 2018 |
| 29499272 | Receptor binding profiles and behavioral pharmacology of ring-substituted N,N-diallyltryptamine analogs. | Neuropharmacology | 2018 |
| 29745330 | Metabolism of Nine Synthetic Cannabinoid Receptor Agonists Encountered in Clinical Casework: Major in vivo Phase I Metabolites of AM-694, AM-2201, JWH-007, JWH-019, JWH-203, JWH-307, MAM-2201, UR-144 and XLR-11 in Human Urine Using LC-MS/MS. | Curr Pharm Biotechnol | 2018 |
| 29542872 | An approach to shortening the timeframe between the emergence of new compounds on the drugs market and the availability of reference standards: The microscale syntheses of nitrazolam and clonazolam for use as reference materials, utilizing polymer-supported reagents. | Drug Test Anal | 2018 |
| 28988906 | Fluorinated phenmetrazine "legal highs" act as substrates for high-affinity monoamine transporters of the SLC6 family. | Neuropharmacology | 2018 |
| 28513099 | Syntheses, analytical and pharmacological characterizations of the 'legal high' 4-[1-(3-methoxyphenyl)cyclohexyl]morpholine (3-MeO-PCMo) and analogues. | Drug Test Anal | 2018 |